APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Radiation Injury Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Radiation Injury Drugs Industry Growth and Trends Forecast to 2032

Report ID 174030560119 December 202591 pages

Choose your research edition.

Industry ResearchRadiation Injury Drugs Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiation Injury Drugs Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Radiation Injury Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiation Injury Drugs Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiation Injury Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Radiation Injury Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Radiation Injury Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Radiation Injury Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Radiation Injury Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Radiation Injury Drugs include Windtree Therapeutics Inc, Tonix Pharmaceuticals Holding Corp, Synedgen Inc, PharmaIN Corp and FirstString Research Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Radiation Injury Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Radiation Injury Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Radiation Injury Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Radiation Injury Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Radiation Injury Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Radiation Injury Drugs Market by Company

Windtree Therapeutics Inc

Tonix Pharmaceuticals Holding Corp

Synedgen Inc

PharmaIN Corp

FirstString Research Inc

Radiation Injury Drugs Segment by Type

DG-3

Des-Asp Angiotensin 1

C-2E5

C-2E2

BMX-001

Aerosurf

Others

Radiation Injury Drugs Segment by Application

Hospital

Clinic

ASCs

Others

Radiation Injury Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiation Injury Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiation Injury Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiation Injury Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Radiation Injury Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Radiation Injury Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of DG-3 Table 2. Major Company of Des-Asp Angiotensin 1 Table 3. Major Company of C-2E5 Table 4. Major Company of C-2E2 Table 5. Major Company of BMX-001 Table 6. Major Company of Aerosurf Table 7. Major Company of Others Table 8. Global Radiation Injury Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global Radiation Injury Drugs Sales by Type (2021-2026) & (K Units) Table 10. Global Radiation Injury Drugs Sales Market Share in Volume by Type (2021-2026) Table 11. Global Radiation Injury Drugs Sales by Type (2021-2026) & (US$ Million) Table 12. Global Radiation Injury Drugs Sales Market Share in Value by Type (2021-2026) Table 13. Global Radiation Injury Drugs Price by Type (2021-2026) & (US$/Unit) Table 14. Global Radiation Injury Drugs Sales by Type (2027-2032) & (K Units) Table 15. Global Radiation Injury Drugs Sales Market Share in Volume by Type (2027-2032) Table 16. Global Radiation Injury Drugs Sales by Type (2027-2032) & (US$ Million) Table 17. Global Radiation Injury Drugs Sales Market Share in Value by Type (2027-2032) Table 18. Global Radiation Injury Drugs Price by Type (2027-2032) & (US$/Unit) Table 19. North America Radiation Injury Drugs Sales by Type (2021-2026) & (K Units) Table 20. North America Radiation Injury Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Europe Radiation Injury Drugs Sales by Type (2021-2026) & (K Units) Table 22. Europe Radiation Injury Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific Radiation Injury Drugs Sales by Type (2021-2026) & (K Units) Table 24. Asia-Pacific Radiation Injury Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America Radiation Injury Drugs Sales by Type (2021-2026) & (K Units) Table 26. Latin America Radiation Injury Drugs Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa Radiation Injury Drugs Sales by Type (2021-2026) & (K Units) Table 28. Middle East and Africa Radiation Injury Drugs Sales by Type (2021-2026) & (US$ Million) Table 29. Radiation Injury Drugs Industry Trends Table 30. Radiation Injury Drugs Industry Drivers Table 31. Radiation Injury Drugs Industry Opportunities and Challenges Table 32. Radiation Injury Drugs Industry Restraints Table 33. Global Radiation Injury Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global Radiation Injury Drugs Revenue Market Share by Company (2021-2026) Table 35. Global Radiation Injury Drugs Sales by Company (2021-2026) & (K Units) Table 36. Global Radiation Injury Drugs Sales Share by Company (2021-2026) Table 37. Global Radiation Injury Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 38. Global Radiation Injury Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global Radiation Injury Drugs Major Company Production Sites and Headquarters Table 40. Global Radiation Injury Drugs Company, Product Type & Application Table 41. Global Radiation Injury Drugs Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global Radiation Injury Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global Radiation Injury Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global Radiation Injury Drugs Sales by Region (2021-2026) & (K Units) Table 46. Global Radiation Injury Drugs Sales Market Share in Volume by Region (2021-2026) Table 47. Global Radiation Injury Drugs Sales by Region (2021-2026) & (US$ Million) Table 48. Global Radiation Injury Drugs Sales Market Share in Value by Region (2021-2026) Table 49. Global Radiation Injury Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 50. Global Radiation Injury Drugs Sales by Region (2027-2032) & (K Units) Table 51. Global Radiation Injury Drugs Sales Market Share in Volume by Region (2027-2032) Table 52. Global Radiation Injury Drugs Sales by Region (2027-2032) & (US$ Million) Table 53. Global Radiation Injury Drugs Sales Market Share in Value by Region (2027-2032) Table 54. Global Radiation Injury Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 55. Global Radiation Injury Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global Radiation Injury Drugs Sales by Application (2021-2026) & (K Units) Table 57. Global Radiation Injury Drugs Sales Market Share in Volume by Application (2021-2026) Table 58. Global Radiation Injury Drugs Sales by Application (2021-2026) & (US$ Million) Table 59. Global Radiation Injury Drugs Sales Market Share in Value by Application (2021-2026) Table 60. Global Radiation Injury Drugs Price by Application (2021-2026) & (US$/Unit) Table 61. Global Radiation Injury Drugs Sales by Application (2027-2032) & (K Units) Table 62. Global Radiation Injury Drugs Sales Market Share in Volume by Application (2027-2032) Table 63. Global Radiation Injury Drugs Sales by Application (2027-2032) & (US$ Million) Table 64. Global Radiation Injury Drugs Sales Market Share in Value by Application (2027-2032) Table 65. Global Radiation Injury Drugs Price by Application (2027-2032) & (US$/Unit) Table 66. North America Radiation Injury Drugs Sales by Application (2021-2026) & (K Units) Table 67. North America Radiation Injury Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Europe Radiation Injury Drugs Sales by Application (2021-2026) & (K Units) Table 69. Europe Radiation Injury Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific Radiation Injury Drugs Sales by Application (2021-2026) & (K Units) Table 71. Asia-Pacific Radiation Injury Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America Radiation Injury Drugs Sales by Application (2021-2026) & (K Units) Table 73. Latin America Radiation Injury Drugs Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa Radiation Injury Drugs Sales by Application (2021-2026) & (K Units) Table 75. Middle East and Africa Radiation Injury Drugs Sales by Application (2021-2026) & (US$ Million) Table 76. Windtree Therapeutics Inc Company Information Table 77. Windtree Therapeutics Inc Business Overview Table 78. Windtree Therapeutics Inc Radiation Injury Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Windtree Therapeutics Inc Radiation Injury Drugs Product Portfolio Table 80. Windtree Therapeutics Inc Recent Development Table 81. Tonix Pharmaceuticals Holding Corp Company Information Table 82. Tonix Pharmaceuticals Holding Corp Business Overview Table 83. Tonix Pharmaceuticals Holding Corp Radiation Injury Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Tonix Pharmaceuticals Holding Corp Radiation Injury Drugs Product Portfolio Table 85. Tonix Pharmaceuticals Holding Corp Recent Development Table 86. Synedgen Inc Company Information Table 87. Synedgen Inc Business Overview Table 88. Synedgen Inc Radiation Injury Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Synedgen Inc Radiation Injury Drugs Product Portfolio Table 90. Synedgen Inc Recent Development Table 91. PharmaIN Corp Company Information Table 92. PharmaIN Corp Business Overview Table 93. PharmaIN Corp Radiation Injury Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. PharmaIN Corp Radiation Injury Drugs Product Portfolio Table 95. PharmaIN Corp Recent Development Table 96. FirstString Research Inc Company Information Table 97. FirstString Research Inc Business Overview Table 98. FirstString Research Inc Radiation Injury Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. FirstString Research Inc Radiation Injury Drugs Product Portfolio Table 100. FirstString Research Inc Recent Development Table 101. North America Radiation Injury Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. North America Radiation Injury Drugs Sales by Country (2021-2026) & (K Units) Table 103. North America Radiation Injury Drugs Sales Market Share by Country (2021-2026) Table 104. North America Radiation Injury Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 105. North America Radiation Injury Drugs Sales Market Share Forecast by Country (2027-2032) Table 106. North America Radiation Injury Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Radiation Injury Drugs Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Radiation Injury Drugs Market Share by Country (2021-2026) Table 109. North America Radiation Injury Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Radiation Injury Drugs Market Share Forecast by Country (2027-2032) Table 111. Europe Radiation Injury Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Europe Radiation Injury Drugs Sales by Country (2021-2026) & (K Units) Table 113. Europe Radiation Injury Drugs Sales Market Share by Country (2021-2026) Table 114. Europe Radiation Injury Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 115. Europe Radiation Injury Drugs Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Radiation Injury Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Radiation Injury Drugs Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Radiation Injury Drugs Market Share by Country (2021-2026) Table 119. Europe Radiation Injury Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Radiation Injury Drugs Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Radiation Injury Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Radiation Injury Drugs Sales by Country (2021-2026) & (K Units) Table 123. Asia-Pacific Radiation Injury Drugs Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Radiation Injury Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 125. Asia-Pacific Radiation Injury Drugs Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Radiation Injury Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Radiation Injury Drugs Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Radiation Injury Drugs Market Share by Country (2021-2026) Table 129. Asia-Pacific Radiation Injury Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Radiation Injury Drugs Market Share Forecast by Country (2027-2032) Table 131. Latin America Radiation Injury Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Latin America Radiation Injury Drugs Sales by Country (2021-2026) & (K Units) Table 133. Latin America Radiation Injury Drugs Sales Market Share by Country (2021-2026) Table 134. Latin America Radiation Injury Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 135. Latin America Radiation Injury Drugs Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Radiation Injury Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Radiation Injury Drugs Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Radiation Injury Drugs Market Share by Country (2021-2026) Table 139. Latin America Radiation Injury Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Radiation Injury Drugs Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Radiation Injury Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Radiation Injury Drugs Sales by Country (2021-2026) & (K Units) Table 143. Middle East and Africa Radiation Injury Drugs Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Radiation Injury Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Radiation Injury Drugs Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Radiation Injury Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Radiation Injury Drugs Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Radiation Injury Drugs Market Share by Country (2021-2026) Table 149. Middle East and Africa Radiation Injury Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Radiation Injury Drugs Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Radiation Injury Drugs Distributors List Table 154. Radiation Injury Drugs Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Radiation Injury Drugs Image Figure 2. Global Radiation Injury Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radiation Injury Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Radiation Injury Drugs Sales (2021-2032) & (K Units) Figure 5. DG-3 Image Figure 6. Global DG-3 Sales YoY Growth (2021-2032) & (K Units) Figure 7. Des-Asp Angiotensin 1 Image Figure 8. Global Des-Asp Angiotensin 1 Sales YoY Growth (2021-2032) & (K Units) Figure 9. C-2E5 Image Figure 10. Global C-2E5 Sales YoY Growth (2021-2032) & (K Units) Figure 11. C-2E2 Image Figure 12. Global C-2E2 Sales YoY Growth (2021-2032) & (K Units) Figure 13. BMX-001 Image Figure 14. Global BMX-001 Sales YoY Growth (2021-2032) & (K Units) Figure 15. Aerosurf Image Figure 16. Global Aerosurf Sales YoY Growth (2021-2032) & (K Units) Figure 17. Others Image Figure 18. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 19. Global Radiation Injury Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global Radiation Injury Drugs Market Share by Type 2025 VS 2032 Figure 21. North America Radiation Injury Drugs Sales Market Share in Volume by Type in 2025 Figure 22. North America Radiation Injury Drugs Sales Market Share in Value by Type in 2025 Figure 23. Europe Radiation Injury Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Europe Radiation Injury Drugs Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific Radiation Injury Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific Radiation Injury Drugs Sales Market Share in Value by Type in 2025 Figure 27. Latin America Radiation Injury Drugs Sales Market Share in Volume by Type in 2025 Figure 28. Latin America Radiation Injury Drugs Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa Radiation Injury Drugs Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa Radiation Injury Drugs Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 Radiation Injury Drugs Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Hospital Image Figure 34. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 35. Clinic Image Figure 36. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 37. ASCs Image Figure 38. Global ASCs Sales YoY Growth (2021-2032) & (K Units) Figure 39. Others Image Figure 40. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 41. Global Radiation Injury Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Radiation Injury Drugs Market Share by Application 2025 VS 2032 Figure 43. North America Radiation Injury Drugs Sales Market Share in Volume by Application in 2025 Figure 44. North America Radiation Injury Drugs Sales Market Share in Value by Application in 2025 Figure 45. Europe Radiation Injury Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Europe Radiation Injury Drugs Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Radiation Injury Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Radiation Injury Drugs Sales Market Share in Value by Application in 2025 Figure 49. Latin America Radiation Injury Drugs Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Radiation Injury Drugs Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Radiation Injury Drugs Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Radiation Injury Drugs Sales Market Share in Value by Application in 2025 Figure 53. North America Radiation Injury Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. North America Radiation Injury Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Radiation Injury Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Radiation Injury Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Radiation Injury Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Europe Radiation Injury Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Radiation Injury Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Radiation Injury Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Radiation Injury Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Asia-Pacific Radiation Injury Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Radiation Injury Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Radiation Injury Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Radiation Injury Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Latin America Radiation Injury Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Radiation Injury Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Radiation Injury Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Radiation Injury Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 70. Middle East and Africa Radiation Injury Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Radiation Injury Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Radiation Injury Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Radiation Injury Drugs Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Radiation Injury Drugs Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • DG-3
  • Des-Asp Angiotensin 1
  • C-2E5
  • C-2E2
  • BMX-001
  • Aerosurf
  • Others
Applications
  • Hospital
  • Clinic
  • ASCs
  • Others
Companies covered
  • Windtree Therapeutics Inc
  • Tonix Pharmaceuticals Holding Corp
  • Synedgen Inc
  • PharmaIN Corp
  • FirstString Research Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Radiation Injury Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Radiation Injury Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Radiation Injury Drugs Market by Type
  6. 1.3.1 DG-3
  7. 1.3.2 Des-Asp Angiotensin 1
  8. 1.3.3 C-2E5
  9. 1.3.4 C-2E2
  10. 1.3.5 BMX-001
  11. 1.3.6 Aerosurf
  12. 1.3.7 Others
  13. 1.4 Global Radiation Injury Drugs Market Size by Type
  14. 1.4.1 Global Radiation Injury Drugs Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global Radiation Injury Drugs Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global Radiation Injury Drugs Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America Radiation Injury Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe Radiation Injury Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific Radiation Injury Drugs Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America Radiation Injury Drugs Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa Radiation Injury Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Radiation Injury Drugs Industry Trends
  2. 2.2 Radiation Injury Drugs Industry Drivers
  3. 2.3 Radiation Injury Drugs Industry Opportunities and Challenges
  4. 2.4 Radiation Injury Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Radiation Injury Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Radiation Injury Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Radiation Injury Drugs Price (2021-2026)
  4. 3.4 Global Radiation Injury Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Radiation Injury Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Radiation Injury Drugs Company, Product Type & Application
  7. 3.7 Global Radiation Injury Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Radiation Injury Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Radiation Injury Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Radiation Injury Drugs Tier 1, Tier 2, and Tier 3
4 Radiation Injury Drugs Regional Status and Outlook
  1. 4.1 Global Radiation Injury Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Radiation Injury Drugs Historic Market Size by Region
  3. 4.2.1 Global Radiation Injury Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Radiation Injury Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Radiation Injury Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Radiation Injury Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Radiation Injury Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Radiation Injury Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Radiation Injury Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Radiation Injury Drugs by Application
  1. 5.1 Radiation Injury Drugs Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 ASCs
  5. 5.1.4 Others
  6. 5.2 Global Radiation Injury Drugs Market Size by Application
  7. 5.2.1 Global Radiation Injury Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Radiation Injury Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Radiation Injury Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Radiation Injury Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Radiation Injury Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Radiation Injury Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Radiation Injury Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Radiation Injury Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Windtree Therapeutics Inc
  2. 6.1.1 Windtree Therapeutics Inc Company Information
  3. 6.1.2 Windtree Therapeutics Inc Business Overview
  4. 6.1.3 Windtree Therapeutics Inc Radiation Injury Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Windtree Therapeutics Inc Radiation Injury Drugs Product Portfolio
  6. 6.1.5 Windtree Therapeutics Inc Recent Developments
  7. 6.2 Tonix Pharmaceuticals Holding Corp
  8. 6.2.1 Tonix Pharmaceuticals Holding Corp Company Information
  9. 6.2.2 Tonix Pharmaceuticals Holding Corp Business Overview
  10. 6.2.3 Tonix Pharmaceuticals Holding Corp Radiation Injury Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Tonix Pharmaceuticals Holding Corp Radiation Injury Drugs Product Portfolio
  12. 6.2.5 Tonix Pharmaceuticals Holding Corp Recent Developments
  13. 6.3 Synedgen Inc
  14. 6.3.1 Synedgen Inc Company Information
  15. 6.3.2 Synedgen Inc Business Overview
  16. 6.3.3 Synedgen Inc Radiation Injury Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Synedgen Inc Radiation Injury Drugs Product Portfolio
  18. 6.3.5 Synedgen Inc Recent Developments
  19. 6.4 PharmaIN Corp
  20. 6.4.1 PharmaIN Corp Company Information
  21. 6.4.2 PharmaIN Corp Business Overview
  22. 6.4.3 PharmaIN Corp Radiation Injury Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 PharmaIN Corp Radiation Injury Drugs Product Portfolio
  24. 6.4.5 PharmaIN Corp Recent Developments
  25. 6.5 FirstString Research Inc
  26. 6.5.1 FirstString Research Inc Company Information
  27. 6.5.2 FirstString Research Inc Business Overview
  28. 6.5.3 FirstString Research Inc Radiation Injury Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 FirstString Research Inc Radiation Injury Drugs Product Portfolio
  30. 6.5.5 FirstString Research Inc Recent Developments
7 North America by Country
  1. 7.1 North America Radiation Injury Drugs Sales by Country
  2. 7.1.1 North America Radiation Injury Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Radiation Injury Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Radiation Injury Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Radiation Injury Drugs Market Size by Country
  6. 7.2.1 North America Radiation Injury Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Radiation Injury Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Radiation Injury Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Radiation Injury Drugs Sales by Country
  2. 8.1.1 Europe Radiation Injury Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Radiation Injury Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Radiation Injury Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Radiation Injury Drugs Market Size by Country
  6. 8.2.1 Europe Radiation Injury Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Radiation Injury Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Radiation Injury Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Radiation Injury Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Radiation Injury Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Radiation Injury Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Radiation Injury Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Radiation Injury Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Radiation Injury Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Radiation Injury Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Radiation Injury Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Radiation Injury Drugs Sales by Country
  2. 10.1.1 South America Radiation Injury Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Radiation Injury Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Radiation Injury Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Radiation Injury Drugs Market Size by Country
  6. 10.2.1 South America Radiation Injury Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Radiation Injury Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Radiation Injury Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Radiation Injury Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Radiation Injury Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Radiation Injury Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Radiation Injury Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Radiation Injury Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Radiation Injury Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Radiation Injury Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Radiation Injury Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Radiation Injury Drugs Value Chain Analysis
  2. 12.1.1 Radiation Injury Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Radiation Injury Drugs Production Mode & Process
  7. 12.2 Radiation Injury Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Radiation Injury Drugs Distributors
  10. 12.2.3 Radiation Injury Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst